You are here

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
Electronic pages
Correspondence
Treatment of chronic hepatitis C complicated by mixed cryoglobulinemia with new protease inhibitor, sofosbuvir
  1. Jonathan G Stine,
  2. Scott Cornella,
  3. Neeral L Shah
  1. Correspondence to Dr Jonathan G Stine, University of Virginia, USA; jgs9f{at}virginia.edu

https://doi.org/10.1136/annrheumdis-2014-206180

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Article citation: Saadoun D, Rigon MR, Thibault V, et al. Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis 2014;73:831–7.

    The lack of data showing the effective clearance of cryoglobulins with the addition of direct acting antiviral drugs is problematic, where close to 50% of patients with chronic hepatitis C (HCV) have cryoglobulinemia.1 The original article by Saadoun et al.2 is timely and sheds light on this large subset of chronic HCV …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Correction
      Correction
      BMJ Publishing Group Ltd and European League Against Rheumatism
      Annals of the Rheumatic Diseases 2015; 74 2102-2102 Published Online First: 09 Oct 2015. doi: 10.1136/annrheumdis-2014-206180corr1